Blonanserin versus risperidone for schizophrenia
Information
- DOI:
- https://doi.org/10.1002/14651858.CD012587Copy DOI
- Database:
-
- Cochrane Database of Systematic Reviews
- Version published:
-
- 09 March 2017see what's new
- Type:
-
- Intervention
- Stage:
-
- Protocol
- Cochrane Editorial Group:
-
Cochrane Schizophrenia Group
- Copyright:
-
- Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Article metrics
Altmetric:
Cited by:
Authors
Contributions of authors
TT: Designed and wrote protocol
NHM: Helped with writing of protocol, final drafting of protocol.
MA: Helped with writing of protocol, final drafting of protocol.
Sources of support
Internal sources
-
The University of Nottingham, UK.
Review authors are students at the University of Nottingham
External sources
-
No external source of support provided, Other.
Declarations of interest
TT: None known
NHM: None known
MK: None known
Acknowledgements
The Cochrane Schizophrenia Group Editorial Base in Nottingham produces and maintains standard text for use in the Methods section of their reviews. We have used this text as the basis of what appears here and adapted it as required.
We would like to the acknowledge the contributions of Jennifer Denyer, Shahin Munir, Danielle Beaton, and Grace Slights who wrote an initial draft for this protocol as part of their postgraduate studies with The University of Nottingham.
If review authors can not reach consensus on trial selection or data extraction Clive E Adams, from Cochrane Schizophrenia, has agreed to help with reaching a final decision.
We would also like to thank Xue Li for peer reviewing this protocol.
Version history
| Published | Title | Stage | Authors | Version |
| 2017 Mar 09 | Blonanserin versus risperidone for schizophrenia | Protocol | Tarek Turk, Natalia Hernandez Morfin, Mahmoud Alkhatib | |
